Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20369177 | 1.00 | TK1 (0.42) | TK1LMNATSHRALBPKM | |
| SCHEMBL25914465 | 0.86 | TK2 (0.33) | TK1LMNATSHRALBPKM | |
| SCHEMBL28675451 | 0.86 | TK1 (0.43) | TK1LMNATSHRALBPKM | |
| 3-Methylthymidine SCHEMBL28122219 | 0.86 | TK1 (0.50) | TK1LMNATSHRBLMPMP22 | |
| 3-Methylthymidine SCHEMBL17794002 | 0.86 | TK1 (0.50) | TK1LMNATSHRBLMPMP22 | |
| 3-Methylthymidine SCHEMBL6062749 | 0.86 | TK1 (0.50) | TK1LMNATSHRBLMPMP22 | |
| 3-Methylthymidine SCHEMBL2246880 | 0.86 | TK1 (0.50) | TK1LMNATSHRBLMPMP22 | |
| SCHEMBL23714838 | 0.85 | TK1 (0.36) | TK1 | |
| SCHEMBL21305425 | 0.85 | TK1 (0.36) | TK1 | |
| SCHEMBL17920476 | 0.82 | RNASE1 (0.45) | TK1LMNATSHRALBPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160024011-A1 | Multi-API Loading Prodrugs | ALKERMES PHARMA IRELAND LTD (IE) | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024011-A1 | Multi-API Loading Prodrugs | AADAC, PAICS, ABCG2 | TK1 1115/4885LMNA 2855/4885TSHR 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.